In recent days, Bausch Health Companies launched an offer to exchange up to US$1.6 billion of its 4.875% and 11.00% Senior Secured Notes due 2028 for new 10.00% Senior Secured Notes due 2032, with ...

Bausch Health (BHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Against a minimalist background of billowing white fabric, “Sweet Mambo” unfolds as a series of contrasting vignettes probing the emotional impact of building and losing interpersonal relationships.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the ...

The national drink of Puerto Rico deserves the classic four-ingredient recipe. Prairie Rose is Food & Wine's senior drinks editor. A trained sommelier, cocktail book author, and wine and spirits ...

Bausch Health Companies Inc. (NYSE:BHC) on Tuesday agreed to indirectly acquire DURECT Corp (NASDAQ:DRRX), including a novel therapeutic molecule, larsucosterol. Larsucosterol, an endogenous sulfated ...

Bausch Health has struck a deal to buy Durect for $63 million upfront, landing a phase 3-ready liver disease candidate that the companies believe has blockbuster potential. Durect reported top-line ...

Shares of Bausch + Lomb (NYSE:BLCO) fell on Wednesday after the Canadian eyecare company announced lower-than-expected financials for Q1 2025 and trimmed its full-year growth outlook, citing ...

Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the eye care unit’s ratings will continue to be under pressure unless the two ...

Forbes contributors publish independent expert analyses and insights. Emily writes about what’s in your glass and why it matters. Few cocktails capture the feeling of a tropical escape like the Piña ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...

March 27 (Reuters) - Bausch + Lomb (BLCO.TO), opens new tab said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not ...